Related Experiment Video
Updated: Sep 20, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents
Allison M Blatz1, Adrienne G Randolph2
1Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA 19104, USA.
Insights
Severe COVID-19 complications like acute respiratory failure and multisystem inflammatory syndrome in children (MIS-C) are rare in pediatric patients. These critical conditions often necessitate intensive care unit (ICU) support and specific treatments like immunomodulation for MIS-C.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Immunology
Background:
- Severe complications from COVID-19 are infrequent in pediatric populations.
- Key severe outcomes include acute respiratory failure and multisystem inflammatory syndrome in children (MIS-C).
- MIS-C is a post-SARS-CoV-2 infection syndrome, typically emerging 3-6 weeks after mild or asymptomatic infection.
Purpose of the Study:
- To summarize the nature of severe COVID-19 complications in children and adolescents.
- To highlight the critical care needs and therapeutic strategies for these conditions.
Main Methods:
- Literature review and synthesis of clinical observations regarding pediatric COVID-19 complications.
- Analysis of treatment approaches for acute respiratory failure and MIS-C.
Main Results:
- Acute respiratory failure and MIS-C are the primary life-threatening complications in pediatric COVID-19.
- Both conditions frequently require intensive care unit (ICU) admission.
- Immunomodulatory therapy is a key treatment for critical MIS-C to manage hyperinflammation and sequelae.
Conclusions:
- While rare, severe COVID-19 complications in children demand prompt recognition and intensive care.
- Management strategies focus on supportive care for respiratory failure and immunomodulation for MIS-C to mitigate severe outcomes.
Abstract:
Severe complications related to COVID-19 occur infrequently in children and adolescents. these life-threatening complications are mainly acute respiratory failure from acute COVID-19 and multisystem inflammatory syndrome in children (MIS-C). MIS-C is a postinfectious complication occurring approximately 3 to 6 weeks mostly after an asymptomatic or mild SARS-CoV-2 infection. For both types of complications, supportive ICU care is often required. For MIS-C critical illness, immunomodulation is prescribed to reverse hyperinflammation and its cardiac and other sequelae.
Related Concept Videos
Myocarditis III: Medical Management
Acute Coronary Syndrome I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Myocarditis I: Introduction

